Palm Beach Gardens, FL, September 3, 2024—Forward Therapeutics, Inc., a next-generation biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders, today announced the appointment of Ulrich Thienel, M.D., Ph.D., as its Chief Medical Officer.
Dr. Thienel will be responsible for building and guiding Forward’s clinical programs, overseeing its clinical development and operations in the US and abroad. … Read the rest
Forward Therapeutics Announces $50 Million Series A Financing to Advance Next-Generation Small Molecule Immune Therapies
Forward Therapeutics Announces $50 Million Series A Financing to Advance Next-Generation Small Molecule
Forward Therapeutics, Inc., a biopharmaceutical company developing next-generation small molecule therapies for chronic immunological and inflammatory disorders, today announced a $50 million Series A financing.… Read the rest
Palm Beach Gardens, FL, September 3, 2024—Forward Therapeutics, Inc., a next-generation biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders, today announced the appointment of Ulrich Thienel, M.D., Ph.D., as its Chief Medical Officer.
Dr. Thienel will be responsible for building and guiding Forward’s clinical programs, overseeing its clinical development and operations in the US and abroad. … Read the rest